| Application no. and date | 17175788.3 (espacenet) (Federated) (European Patent Register), 20110224 | | Patent/reg. no. and date | DK/EP 3251660, 20191016 | | Publication date | 20171206 | | Priority no. and date | US 308056 P, 20100225 | | EP pub. no. and date |
EP 3251660 20171206 | | Effective date | | | Applicant/owner | Pfizer Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US,
Bristol-Myers Squibb Holdings Ireland
Unlimited Company, Hinterbergstrasse 16
6312 Steinhausen, CH | | Applicant ref. no. | V152390DK | | Inventor | PATEL, Jatin, c/o Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princton, NJ New Jersey 08543, US,
FROST, Charles, c/o Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princton, NJ New Jersey 08543, US,
JIA, Jingpin, c/o Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princton, NJ New Jersey 08543, US,
VEMA-VARAPU, Chandra, c/o Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princton, NJ New Jersey 08543, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/4545 (2006.01) , A61K 9/20 (2006.01) , A61P 7/02 (2006.01) | | Title | APIXABANFORMULERINGER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
